Fulltext

Renovascular hypertension: screening and modern management

Baumgartner, Iris ; Lerman, Lilach O.

In: European Heart Journal, 2011, vol. 32, no. 13, p. 1590-1598

Ajouter à la liste personnelle
    Titre
    • Renovascular hypertension: screening and modern management
    Auteur
    • Baumgartner, Iris. Department of Clinical and Interventional Angiology, Swiss Cardiovascular Center, University of Bern, Switzerland
    • Lerman, Lilach O.. The Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA
    Type de document
    • Postprint
    Langue
    • Anglais
    Publié dans
    • European Heart Journal, 2011, vol. 32, no. 13, p. 1590-1598. Oxford University Press
    Autre version électronique
    Identifiant OAI-PMH
    • oai:doc.rero.ch:290041
    Summary
    The diagnosis and management of patients with renovascular disease and hypertension continue to elude healthcare providers. The advent of novel imaging and interventional techniques, and increased understanding of the pathways leading to irreversible renal injury and renovascular hypertension, have ushered in commendable attempts to optimize and finetune strategies to preserve or restore renal function and control blood pressure. Large randomized clinical trials that compare different forms of therapy, and smaller trials that test novel experimental treatments, will hopefully help formulate innovative concepts and tools to manage the patient population with atherosclerotic renovascular disease